nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—MAPT—Alzheimer's disease	0.45	0.892	CbGaD
Lansoprazole—CYP2D6—Alzheimer's disease	0.0546	0.108	CbGaD
Lansoprazole—CYP2D6—Rivastigmine—Alzheimer's disease	0.0432	0.179	CbGbCtD
Lansoprazole—CYP2C19—Memantine—Alzheimer's disease	0.0394	0.164	CbGbCtD
Lansoprazole—CYP2C9—Donepezil—Alzheimer's disease	0.0378	0.157	CbGbCtD
Lansoprazole—CYP2D6—Donepezil—Alzheimer's disease	0.0345	0.143	CbGbCtD
Lansoprazole—CYP3A4—Rivastigmine—Alzheimer's disease	0.0275	0.114	CbGbCtD
Lansoprazole—CYP2D6—Galantamine—Alzheimer's disease	0.0223	0.0924	CbGbCtD
Lansoprazole—CYP3A4—Donepezil—Alzheimer's disease	0.022	0.0912	CbGbCtD
Lansoprazole—CYP3A4—Galantamine—Alzheimer's disease	0.0142	0.0588	CbGbCtD
Lansoprazole—MAPT—telencephalon—Alzheimer's disease	0.000634	0.141	CbGeAlD
Lansoprazole—MAPT—cerebellum—Alzheimer's disease	0.000352	0.0786	CbGeAlD
Lansoprazole—MAPT—brain—Alzheimer's disease	0.000286	0.0638	CbGeAlD
Lansoprazole—Rabeprazole—CYP2D6—Alzheimer's disease	0.000281	0.551	CrCbGaD
Lansoprazole—ATP4A—nervous system—Alzheimer's disease	0.000278	0.062	CbGeAlD
Lansoprazole—ATP4A—central nervous system—Alzheimer's disease	0.000267	0.0597	CbGeAlD
Lansoprazole—ATP4A—cerebellum—Alzheimer's disease	0.000261	0.0583	CbGeAlD
Lansoprazole—Omeprazole—CYP2D6—Alzheimer's disease	0.000229	0.449	CrCbGaD
Lansoprazole—ATP4A—brain—Alzheimer's disease	0.000212	0.0474	CbGeAlD
Lansoprazole—CYP1B1—telencephalon—Alzheimer's disease	0.000187	0.0418	CbGeAlD
Lansoprazole—ABCB1—blood vessel—Alzheimer's disease	0.000142	0.0316	CbGeAlD
Lansoprazole—ABCG2—telencephalon—Alzheimer's disease	0.00014	0.0311	CbGeAlD
Lansoprazole—Rhinitis—Rivastigmine—Alzheimer's disease	0.000131	0.00077	CcSEcCtD
Lansoprazole—Skin disorder—Galantamine—Alzheimer's disease	0.000131	0.00077	CcSEcCtD
Lansoprazole—Urethral disorder—Memantine—Alzheimer's disease	0.000131	0.000769	CcSEcCtD
Lansoprazole—Hepatitis—Rivastigmine—Alzheimer's disease	0.000131	0.000768	CcSEcCtD
Lansoprazole—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000131	0.000766	CcSEcCtD
Lansoprazole—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00013	0.000764	CcSEcCtD
Lansoprazole—Hallucination—Rivastigmine—Alzheimer's disease	0.00013	0.000764	CcSEcCtD
Lansoprazole—Alopecia—Donepezil—Alzheimer's disease	0.00013	0.000764	CcSEcCtD
Lansoprazole—Pharyngitis—Rivastigmine—Alzheimer's disease	0.00013	0.000762	CcSEcCtD
Lansoprazole—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000129	0.000758	CcSEcCtD
Lansoprazole—Mental disorder—Donepezil—Alzheimer's disease	0.000129	0.000757	CcSEcCtD
Lansoprazole—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000129	0.000756	CcSEcCtD
Lansoprazole—Visual impairment—Memantine—Alzheimer's disease	0.000129	0.000756	CcSEcCtD
Lansoprazole—Anorexia—Galantamine—Alzheimer's disease	0.000129	0.000755	CcSEcCtD
Lansoprazole—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000129	0.000754	CcSEcCtD
Lansoprazole—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000128	0.000753	CcSEcCtD
Lansoprazole—Erythema—Donepezil—Alzheimer's disease	0.000128	0.000752	CcSEcCtD
Lansoprazole—Malnutrition—Donepezil—Alzheimer's disease	0.000128	0.000752	CcSEcCtD
Lansoprazole—Erythema multiforme—Memantine—Alzheimer's disease	0.000127	0.000742	CcSEcCtD
Lansoprazole—Flatulence—Donepezil—Alzheimer's disease	0.000126	0.000741	CcSEcCtD
Lansoprazole—Hypotension—Galantamine—Alzheimer's disease	0.000126	0.00074	CcSEcCtD
Lansoprazole—Visual impairment—Rivastigmine—Alzheimer's disease	0.000126	0.00074	CcSEcCtD
Lansoprazole—Tension—Donepezil—Alzheimer's disease	0.000126	0.000738	CcSEcCtD
Lansoprazole—Dysgeusia—Donepezil—Alzheimer's disease	0.000126	0.000737	CcSEcCtD
Lansoprazole—Eye disorder—Memantine—Alzheimer's disease	0.000125	0.000733	CcSEcCtD
Lansoprazole—Tinnitus—Memantine—Alzheimer's disease	0.000125	0.000732	CcSEcCtD
Lansoprazole—Nervousness—Donepezil—Alzheimer's disease	0.000125	0.000731	CcSEcCtD
Lansoprazole—Cardiac disorder—Memantine—Alzheimer's disease	0.000124	0.000728	CcSEcCtD
Lansoprazole—Back pain—Donepezil—Alzheimer's disease	0.000124	0.000728	CcSEcCtD
Lansoprazole—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000124	0.000726	CcSEcCtD
Lansoprazole—Muscle spasms—Donepezil—Alzheimer's disease	0.000123	0.000723	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000123	0.000722	CcSEcCtD
Lansoprazole—Eye disorder—Rivastigmine—Alzheimer's disease	0.000122	0.000717	CcSEcCtD
Lansoprazole—Insomnia—Galantamine—Alzheimer's disease	0.000122	0.000717	CcSEcCtD
Lansoprazole—Tinnitus—Rivastigmine—Alzheimer's disease	0.000122	0.000716	CcSEcCtD
Lansoprazole—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000122	0.000712	CcSEcCtD
Lansoprazole—Angiopathy—Memantine—Alzheimer's disease	0.000121	0.000712	CcSEcCtD
Lansoprazole—Paraesthesia—Galantamine—Alzheimer's disease	0.000121	0.000711	CcSEcCtD
Lansoprazole—Vision blurred—Donepezil—Alzheimer's disease	0.000121	0.000709	CcSEcCtD
Lansoprazole—Immune system disorder—Memantine—Alzheimer's disease	0.000121	0.000709	CcSEcCtD
Lansoprazole—Mediastinal disorder—Memantine—Alzheimer's disease	0.000121	0.000707	CcSEcCtD
Lansoprazole—Tremor—Donepezil—Alzheimer's disease	0.00012	0.000705	CcSEcCtD
Lansoprazole—Somnolence—Galantamine—Alzheimer's disease	0.00012	0.000704	CcSEcCtD
Lansoprazole—Chills—Memantine—Alzheimer's disease	0.00012	0.000704	CcSEcCtD
Lansoprazole—Arrhythmia—Memantine—Alzheimer's disease	0.00012	0.000701	CcSEcCtD
Lansoprazole—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000119	0.000698	CcSEcCtD
Lansoprazole—Dyspepsia—Galantamine—Alzheimer's disease	0.000119	0.000697	CcSEcCtD
Lansoprazole—Angiopathy—Rivastigmine—Alzheimer's disease	0.000119	0.000697	CcSEcCtD
Lansoprazole—Anaemia—Donepezil—Alzheimer's disease	0.000119	0.000695	CcSEcCtD
Lansoprazole—Alopecia—Memantine—Alzheimer's disease	0.000118	0.000693	CcSEcCtD
Lansoprazole—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000118	0.000692	CcSEcCtD
Lansoprazole—Agitation—Donepezil—Alzheimer's disease	0.000118	0.000691	CcSEcCtD
Lansoprazole—Chills—Rivastigmine—Alzheimer's disease	0.000117	0.000689	CcSEcCtD
Lansoprazole—Decreased appetite—Galantamine—Alzheimer's disease	0.000117	0.000689	CcSEcCtD
Lansoprazole—Mental disorder—Memantine—Alzheimer's disease	0.000117	0.000688	CcSEcCtD
Lansoprazole—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000117	0.000686	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000117	0.000684	CcSEcCtD
Lansoprazole—Malnutrition—Memantine—Alzheimer's disease	0.000117	0.000683	CcSEcCtD
Lansoprazole—Fatigue—Galantamine—Alzheimer's disease	0.000117	0.000683	CcSEcCtD
Lansoprazole—Malaise—Donepezil—Alzheimer's disease	0.000116	0.000678	CcSEcCtD
Lansoprazole—Alopecia—Rivastigmine—Alzheimer's disease	0.000116	0.000678	CcSEcCtD
Lansoprazole—Constipation—Galantamine—Alzheimer's disease	0.000116	0.000678	CcSEcCtD
Lansoprazole—Vertigo—Donepezil—Alzheimer's disease	0.000115	0.000676	CcSEcCtD
Lansoprazole—Syncope—Donepezil—Alzheimer's disease	0.000115	0.000675	CcSEcCtD
Lansoprazole—Flatulence—Memantine—Alzheimer's disease	0.000115	0.000673	CcSEcCtD
Lansoprazole—Mental disorder—Rivastigmine—Alzheimer's disease	0.000115	0.000673	CcSEcCtD
Lansoprazole—Tension—Memantine—Alzheimer's disease	0.000114	0.00067	CcSEcCtD
Lansoprazole—Dysgeusia—Memantine—Alzheimer's disease	0.000114	0.000669	CcSEcCtD
Lansoprazole—Malnutrition—Rivastigmine—Alzheimer's disease	0.000114	0.000668	CcSEcCtD
Lansoprazole—Erythema—Rivastigmine—Alzheimer's disease	0.000114	0.000668	CcSEcCtD
Lansoprazole—Nervousness—Memantine—Alzheimer's disease	0.000113	0.000663	CcSEcCtD
Lansoprazole—Loss of consciousness—Donepezil—Alzheimer's disease	0.000113	0.000661	CcSEcCtD
Lansoprazole—Back pain—Memantine—Alzheimer's disease	0.000113	0.000661	CcSEcCtD
Lansoprazole—Flatulence—Rivastigmine—Alzheimer's disease	0.000112	0.000659	CcSEcCtD
Lansoprazole—Cough—Donepezil—Alzheimer's disease	0.000112	0.000657	CcSEcCtD
Lansoprazole—Tension—Rivastigmine—Alzheimer's disease	0.000112	0.000656	CcSEcCtD
Lansoprazole—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000112	0.000654	CcSEcCtD
Lansoprazole—Feeling abnormal—Galantamine—Alzheimer's disease	0.000111	0.000653	CcSEcCtD
Lansoprazole—Convulsion—Donepezil—Alzheimer's disease	0.000111	0.000652	CcSEcCtD
Lansoprazole—Hypertension—Donepezil—Alzheimer's disease	0.000111	0.00065	CcSEcCtD
Lansoprazole—Nervousness—Rivastigmine—Alzheimer's disease	0.000111	0.000649	CcSEcCtD
Lansoprazole—CYP1B1—nervous system—Alzheimer's disease	0.000111	0.0247	CbGeAlD
Lansoprazole—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000111	0.000648	CcSEcCtD
Lansoprazole—Back pain—Rivastigmine—Alzheimer's disease	0.00011	0.000646	CcSEcCtD
Lansoprazole—Vision blurred—Memantine—Alzheimer's disease	0.00011	0.000644	CcSEcCtD
Lansoprazole—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00011	0.000643	CcSEcCtD
Lansoprazole—Arthralgia—Donepezil—Alzheimer's disease	0.000109	0.000641	CcSEcCtD
Lansoprazole—Myalgia—Donepezil—Alzheimer's disease	0.000109	0.000641	CcSEcCtD
Lansoprazole—Chest pain—Donepezil—Alzheimer's disease	0.000109	0.000641	CcSEcCtD
Lansoprazole—Tremor—Memantine—Alzheimer's disease	0.000109	0.00064	CcSEcCtD
Lansoprazole—Anxiety—Donepezil—Alzheimer's disease	0.000109	0.000638	CcSEcCtD
Lansoprazole—Ill-defined disorder—Memantine—Alzheimer's disease	0.000108	0.000634	CcSEcCtD
Lansoprazole—Discomfort—Donepezil—Alzheimer's disease	0.000108	0.000633	CcSEcCtD
Lansoprazole—Anaemia—Memantine—Alzheimer's disease	0.000108	0.000631	CcSEcCtD
Lansoprazole—Vision blurred—Rivastigmine—Alzheimer's disease	0.000107	0.00063	CcSEcCtD
Lansoprazole—Agitation—Memantine—Alzheimer's disease	0.000107	0.000628	CcSEcCtD
Lansoprazole—Dry mouth—Donepezil—Alzheimer's disease	0.000107	0.000626	CcSEcCtD
Lansoprazole—Abdominal pain—Galantamine—Alzheimer's disease	0.000107	0.000626	CcSEcCtD
Lansoprazole—Body temperature increased—Galantamine—Alzheimer's disease	0.000107	0.000626	CcSEcCtD
Lansoprazole—Tremor—Rivastigmine—Alzheimer's disease	0.000107	0.000626	CcSEcCtD
Lansoprazole—CYP1B1—central nervous system—Alzheimer's disease	0.000106	0.0238	CbGeAlD
Lansoprazole—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000106	0.00062	CcSEcCtD
Lansoprazole—Confusional state—Donepezil—Alzheimer's disease	0.000106	0.000619	CcSEcCtD
Lansoprazole—Anaemia—Rivastigmine—Alzheimer's disease	0.000105	0.000618	CcSEcCtD
Lansoprazole—Malaise—Memantine—Alzheimer's disease	0.000105	0.000616	CcSEcCtD
Lansoprazole—Agitation—Rivastigmine—Alzheimer's disease	0.000105	0.000614	CcSEcCtD
Lansoprazole—Oedema—Donepezil—Alzheimer's disease	0.000105	0.000614	CcSEcCtD
Lansoprazole—Vertigo—Memantine—Alzheimer's disease	0.000105	0.000614	CcSEcCtD
Lansoprazole—Syncope—Memantine—Alzheimer's disease	0.000104	0.000613	CcSEcCtD
Lansoprazole—Leukopenia—Memantine—Alzheimer's disease	0.000104	0.000611	CcSEcCtD
Lansoprazole—CYP1B1—cerebellum—Alzheimer's disease	0.000104	0.0232	CbGeAlD
Lansoprazole—Infection—Donepezil—Alzheimer's disease	0.000104	0.00061	CcSEcCtD
Lansoprazole—CYP2D6—forebrain—Alzheimer's disease	0.000104	0.0232	CbGeAlD
Lansoprazole—Shock—Donepezil—Alzheimer's disease	0.000103	0.000604	CcSEcCtD
Lansoprazole—Palpitations—Memantine—Alzheimer's disease	0.000103	0.000604	CcSEcCtD
Lansoprazole—Malaise—Rivastigmine—Alzheimer's disease	0.000103	0.000603	CcSEcCtD
Lansoprazole—Nervous system disorder—Donepezil—Alzheimer's disease	0.000103	0.000602	CcSEcCtD
Lansoprazole—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000103	0.000601	CcSEcCtD
Lansoprazole—Vertigo—Rivastigmine—Alzheimer's disease	0.000102	0.0006	CcSEcCtD
Lansoprazole—Loss of consciousness—Memantine—Alzheimer's disease	0.000102	0.0006	CcSEcCtD
Lansoprazole—Syncope—Rivastigmine—Alzheimer's disease	0.000102	0.000599	CcSEcCtD
Lansoprazole—Cough—Memantine—Alzheimer's disease	0.000102	0.000596	CcSEcCtD
Lansoprazole—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000101	0.000594	CcSEcCtD
Lansoprazole—Convulsion—Memantine—Alzheimer's disease	0.000101	0.000592	CcSEcCtD
Lansoprazole—Palpitations—Rivastigmine—Alzheimer's disease	0.000101	0.000591	CcSEcCtD
Lansoprazole—Hypertension—Memantine—Alzheimer's disease	0.000101	0.00059	CcSEcCtD
Lansoprazole—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.0001	0.000587	CcSEcCtD
Lansoprazole—Anorexia—Donepezil—Alzheimer's disease	9.98e-05	0.000585	CcSEcCtD
Lansoprazole—Hypersensitivity—Galantamine—Alzheimer's disease	9.96e-05	0.000584	CcSEcCtD
Lansoprazole—Cough—Rivastigmine—Alzheimer's disease	9.95e-05	0.000583	CcSEcCtD
Lansoprazole—Chest pain—Memantine—Alzheimer's disease	9.92e-05	0.000582	CcSEcCtD
Lansoprazole—Arthralgia—Memantine—Alzheimer's disease	9.92e-05	0.000582	CcSEcCtD
Lansoprazole—Myalgia—Memantine—Alzheimer's disease	9.92e-05	0.000582	CcSEcCtD
Lansoprazole—Anxiety—Memantine—Alzheimer's disease	9.89e-05	0.00058	CcSEcCtD
Lansoprazole—Convulsion—Rivastigmine—Alzheimer's disease	9.88e-05	0.000579	CcSEcCtD
Lansoprazole—Hypertension—Rivastigmine—Alzheimer's disease	9.84e-05	0.000577	CcSEcCtD
Lansoprazole—Discomfort—Memantine—Alzheimer's disease	9.8e-05	0.000575	CcSEcCtD
Lansoprazole—Hypotension—Donepezil—Alzheimer's disease	9.79e-05	0.000574	CcSEcCtD
Lansoprazole—Myalgia—Rivastigmine—Alzheimer's disease	9.7e-05	0.000569	CcSEcCtD
Lansoprazole—Arthralgia—Rivastigmine—Alzheimer's disease	9.7e-05	0.000569	CcSEcCtD
Lansoprazole—Chest pain—Rivastigmine—Alzheimer's disease	9.7e-05	0.000569	CcSEcCtD
Lansoprazole—Dry mouth—Memantine—Alzheimer's disease	9.7e-05	0.000569	CcSEcCtD
Lansoprazole—Asthenia—Galantamine—Alzheimer's disease	9.7e-05	0.000568	CcSEcCtD
Lansoprazole—Anxiety—Rivastigmine—Alzheimer's disease	9.67e-05	0.000567	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	9.64e-05	0.000565	CcSEcCtD
Lansoprazole—Confusional state—Memantine—Alzheimer's disease	9.59e-05	0.000562	CcSEcCtD
Lansoprazole—Discomfort—Rivastigmine—Alzheimer's disease	9.59e-05	0.000562	CcSEcCtD
Lansoprazole—CYP2D6—telencephalon—Alzheimer's disease	9.56e-05	0.0213	CbGeAlD
Lansoprazole—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	9.54e-05	0.000559	CcSEcCtD
Lansoprazole—Oedema—Memantine—Alzheimer's disease	9.51e-05	0.000558	CcSEcCtD
Lansoprazole—Dry mouth—Rivastigmine—Alzheimer's disease	9.49e-05	0.000556	CcSEcCtD
Lansoprazole—Insomnia—Donepezil—Alzheimer's disease	9.47e-05	0.000555	CcSEcCtD
Lansoprazole—Infection—Memantine—Alzheimer's disease	9.45e-05	0.000554	CcSEcCtD
Lansoprazole—Paraesthesia—Donepezil—Alzheimer's disease	9.4e-05	0.000551	CcSEcCtD
Lansoprazole—Confusional state—Rivastigmine—Alzheimer's disease	9.38e-05	0.00055	CcSEcCtD
Lansoprazole—Shock—Memantine—Alzheimer's disease	9.36e-05	0.000549	CcSEcCtD
Lansoprazole—Dyspnoea—Donepezil—Alzheimer's disease	9.34e-05	0.000547	CcSEcCtD
Lansoprazole—Nervous system disorder—Memantine—Alzheimer's disease	9.33e-05	0.000547	CcSEcCtD
Lansoprazole—Somnolence—Donepezil—Alzheimer's disease	9.31e-05	0.000546	CcSEcCtD
Lansoprazole—Thrombocytopenia—Memantine—Alzheimer's disease	9.31e-05	0.000546	CcSEcCtD
Lansoprazole—Oedema—Rivastigmine—Alzheimer's disease	9.3e-05	0.000545	CcSEcCtD
Lansoprazole—Tachycardia—Memantine—Alzheimer's disease	9.28e-05	0.000544	CcSEcCtD
Lansoprazole—Diarrhoea—Galantamine—Alzheimer's disease	9.25e-05	0.000542	CcSEcCtD
Lansoprazole—Infection—Rivastigmine—Alzheimer's disease	9.24e-05	0.000542	CcSEcCtD
Lansoprazole—Skin disorder—Memantine—Alzheimer's disease	9.24e-05	0.000542	CcSEcCtD
Lansoprazole—Dyspepsia—Donepezil—Alzheimer's disease	9.22e-05	0.000541	CcSEcCtD
Lansoprazole—Hyperhidrosis—Memantine—Alzheimer's disease	9.19e-05	0.000539	CcSEcCtD
Lansoprazole—Shock—Rivastigmine—Alzheimer's disease	9.15e-05	0.000537	CcSEcCtD
Lansoprazole—Nervous system disorder—Rivastigmine—Alzheimer's disease	9.12e-05	0.000535	CcSEcCtD
Lansoprazole—Thrombocytopenia—Rivastigmine—Alzheimer's disease	9.11e-05	0.000534	CcSEcCtD
Lansoprazole—Decreased appetite—Donepezil—Alzheimer's disease	9.1e-05	0.000534	CcSEcCtD
Lansoprazole—Tachycardia—Rivastigmine—Alzheimer's disease	9.08e-05	0.000532	CcSEcCtD
Lansoprazole—Anorexia—Memantine—Alzheimer's disease	9.06e-05	0.000531	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Donepezil—Alzheimer's disease	9.04e-05	0.00053	CcSEcCtD
Lansoprazole—Skin disorder—Rivastigmine—Alzheimer's disease	9.04e-05	0.00053	CcSEcCtD
Lansoprazole—Fatigue—Donepezil—Alzheimer's disease	9.03e-05	0.000529	CcSEcCtD
Lansoprazole—Hyperhidrosis—Rivastigmine—Alzheimer's disease	8.99e-05	0.000527	CcSEcCtD
Lansoprazole—Pain—Donepezil—Alzheimer's disease	8.96e-05	0.000525	CcSEcCtD
Lansoprazole—Constipation—Donepezil—Alzheimer's disease	8.96e-05	0.000525	CcSEcCtD
Lansoprazole—Dizziness—Galantamine—Alzheimer's disease	8.94e-05	0.000524	CcSEcCtD
Lansoprazole—Hypotension—Memantine—Alzheimer's disease	8.89e-05	0.000521	CcSEcCtD
Lansoprazole—Anorexia—Rivastigmine—Alzheimer's disease	8.87e-05	0.00052	CcSEcCtD
Lansoprazole—Hypotension—Rivastigmine—Alzheimer's disease	8.69e-05	0.00051	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Memantine—Alzheimer's disease	8.66e-05	0.000508	CcSEcCtD
Lansoprazole—Feeling abnormal—Donepezil—Alzheimer's disease	8.63e-05	0.000506	CcSEcCtD
Lansoprazole—Insomnia—Memantine—Alzheimer's disease	8.6e-05	0.000504	CcSEcCtD
Lansoprazole—Vomiting—Galantamine—Alzheimer's disease	8.59e-05	0.000504	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Donepezil—Alzheimer's disease	8.56e-05	0.000502	CcSEcCtD
Lansoprazole—Paraesthesia—Memantine—Alzheimer's disease	8.54e-05	0.000501	CcSEcCtD
Lansoprazole—Rash—Galantamine—Alzheimer's disease	8.52e-05	0.0005	CcSEcCtD
Lansoprazole—Dermatitis—Galantamine—Alzheimer's disease	8.51e-05	0.000499	CcSEcCtD
Lansoprazole—Dyspnoea—Memantine—Alzheimer's disease	8.48e-05	0.000497	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	8.48e-05	0.000497	CcSEcCtD
Lansoprazole—Headache—Galantamine—Alzheimer's disease	8.47e-05	0.000496	CcSEcCtD
Lansoprazole—ABCB1—embryo—Alzheimer's disease	8.46e-05	0.0189	CbGeAlD
Lansoprazole—CYP1B1—brain—Alzheimer's disease	8.45e-05	0.0189	CbGeAlD
Lansoprazole—Somnolence—Memantine—Alzheimer's disease	8.45e-05	0.000496	CcSEcCtD
Lansoprazole—Insomnia—Rivastigmine—Alzheimer's disease	8.41e-05	0.000493	CcSEcCtD
Lansoprazole—Dyspepsia—Memantine—Alzheimer's disease	8.37e-05	0.000491	CcSEcCtD
Lansoprazole—Paraesthesia—Rivastigmine—Alzheimer's disease	8.35e-05	0.00049	CcSEcCtD
Lansoprazole—Urticaria—Donepezil—Alzheimer's disease	8.32e-05	0.000488	CcSEcCtD
Lansoprazole—Dyspnoea—Rivastigmine—Alzheimer's disease	8.29e-05	0.000486	CcSEcCtD
Lansoprazole—Body temperature increased—Donepezil—Alzheimer's disease	8.28e-05	0.000485	CcSEcCtD
Lansoprazole—Abdominal pain—Donepezil—Alzheimer's disease	8.28e-05	0.000485	CcSEcCtD
Lansoprazole—Somnolence—Rivastigmine—Alzheimer's disease	8.27e-05	0.000485	CcSEcCtD
Lansoprazole—Decreased appetite—Memantine—Alzheimer's disease	8.27e-05	0.000485	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Memantine—Alzheimer's disease	8.21e-05	0.000481	CcSEcCtD
Lansoprazole—Fatigue—Memantine—Alzheimer's disease	8.2e-05	0.000481	CcSEcCtD
Lansoprazole—Dyspepsia—Rivastigmine—Alzheimer's disease	8.19e-05	0.00048	CcSEcCtD
Lansoprazole—Constipation—Memantine—Alzheimer's disease	8.13e-05	0.000477	CcSEcCtD
Lansoprazole—Pain—Memantine—Alzheimer's disease	8.13e-05	0.000477	CcSEcCtD
Lansoprazole—Decreased appetite—Rivastigmine—Alzheimer's disease	8.09e-05	0.000474	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	8.03e-05	0.000471	CcSEcCtD
Lansoprazole—Nausea—Galantamine—Alzheimer's disease	8.03e-05	0.000471	CcSEcCtD
Lansoprazole—Fatigue—Rivastigmine—Alzheimer's disease	8.02e-05	0.00047	CcSEcCtD
Lansoprazole—Constipation—Rivastigmine—Alzheimer's disease	7.95e-05	0.000466	CcSEcCtD
Lansoprazole—Pain—Rivastigmine—Alzheimer's disease	7.95e-05	0.000466	CcSEcCtD
Lansoprazole—Feeling abnormal—Memantine—Alzheimer's disease	7.84e-05	0.000459	CcSEcCtD
Lansoprazole—CYP1A1—nervous system—Alzheimer's disease	7.82e-05	0.0174	CbGeAlD
Lansoprazole—Gastrointestinal pain—Memantine—Alzheimer's disease	7.78e-05	0.000456	CcSEcCtD
Lansoprazole—ABCG2—cerebellum—Alzheimer's disease	7.75e-05	0.0173	CbGeAlD
Lansoprazole—Hypersensitivity—Donepezil—Alzheimer's disease	7.72e-05	0.000452	CcSEcCtD
Lansoprazole—Feeling abnormal—Rivastigmine—Alzheimer's disease	7.67e-05	0.000449	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	7.61e-05	0.000446	CcSEcCtD
Lansoprazole—Urticaria—Memantine—Alzheimer's disease	7.55e-05	0.000443	CcSEcCtD
Lansoprazole—CYP1A1—central nervous system—Alzheimer's disease	7.53e-05	0.0168	CbGeAlD
Lansoprazole—Body temperature increased—Memantine—Alzheimer's disease	7.52e-05	0.000441	CcSEcCtD
Lansoprazole—Abdominal pain—Memantine—Alzheimer's disease	7.52e-05	0.000441	CcSEcCtD
Lansoprazole—Asthenia—Donepezil—Alzheimer's disease	7.51e-05	0.000441	CcSEcCtD
Lansoprazole—ABCB1—forebrain—Alzheimer's disease	7.48e-05	0.0167	CbGeAlD
Lansoprazole—Pruritus—Donepezil—Alzheimer's disease	7.41e-05	0.000434	CcSEcCtD
Lansoprazole—Urticaria—Rivastigmine—Alzheimer's disease	7.39e-05	0.000433	CcSEcCtD
Lansoprazole—Body temperature increased—Rivastigmine—Alzheimer's disease	7.35e-05	0.000431	CcSEcCtD
Lansoprazole—Abdominal pain—Rivastigmine—Alzheimer's disease	7.35e-05	0.000431	CcSEcCtD
Lansoprazole—Diarrhoea—Donepezil—Alzheimer's disease	7.17e-05	0.00042	CcSEcCtD
Lansoprazole—Hypersensitivity—Memantine—Alzheimer's disease	7.01e-05	0.000411	CcSEcCtD
Lansoprazole—Dizziness—Donepezil—Alzheimer's disease	6.93e-05	0.000406	CcSEcCtD
Lansoprazole—ABCB1—telencephalon—Alzheimer's disease	6.88e-05	0.0154	CbGeAlD
Lansoprazole—Hypersensitivity—Rivastigmine—Alzheimer's disease	6.85e-05	0.000402	CcSEcCtD
Lansoprazole—Asthenia—Memantine—Alzheimer's disease	6.82e-05	0.0004	CcSEcCtD
Lansoprazole—Pruritus—Memantine—Alzheimer's disease	6.73e-05	0.000394	CcSEcCtD
Lansoprazole—Asthenia—Rivastigmine—Alzheimer's disease	6.67e-05	0.000391	CcSEcCtD
Lansoprazole—Vomiting—Donepezil—Alzheimer's disease	6.66e-05	0.00039	CcSEcCtD
Lansoprazole—Rash—Donepezil—Alzheimer's disease	6.6e-05	0.000387	CcSEcCtD
Lansoprazole—Dermatitis—Donepezil—Alzheimer's disease	6.6e-05	0.000387	CcSEcCtD
Lansoprazole—Pruritus—Rivastigmine—Alzheimer's disease	6.58e-05	0.000386	CcSEcCtD
Lansoprazole—Headache—Donepezil—Alzheimer's disease	6.56e-05	0.000385	CcSEcCtD
Lansoprazole—Diarrhoea—Memantine—Alzheimer's disease	6.51e-05	0.000381	CcSEcCtD
Lansoprazole—CYP2C8—brain—Alzheimer's disease	6.47e-05	0.0144	CbGeAlD
Lansoprazole—Diarrhoea—Rivastigmine—Alzheimer's disease	6.36e-05	0.000373	CcSEcCtD
Lansoprazole—ABCG2—brain—Alzheimer's disease	6.3e-05	0.014	CbGeAlD
Lansoprazole—Dizziness—Memantine—Alzheimer's disease	6.29e-05	0.000369	CcSEcCtD
Lansoprazole—Nausea—Donepezil—Alzheimer's disease	6.22e-05	0.000365	CcSEcCtD
Lansoprazole—Dizziness—Rivastigmine—Alzheimer's disease	6.15e-05	0.000361	CcSEcCtD
Lansoprazole—Vomiting—Memantine—Alzheimer's disease	6.05e-05	0.000354	CcSEcCtD
Lansoprazole—Rash—Memantine—Alzheimer's disease	6e-05	0.000352	CcSEcCtD
Lansoprazole—Dermatitis—Memantine—Alzheimer's disease	5.99e-05	0.000351	CcSEcCtD
Lansoprazole—CYP1A1—brain—Alzheimer's disease	5.98e-05	0.0133	CbGeAlD
Lansoprazole—Headache—Memantine—Alzheimer's disease	5.96e-05	0.000349	CcSEcCtD
Lansoprazole—Vomiting—Rivastigmine—Alzheimer's disease	5.91e-05	0.000347	CcSEcCtD
Lansoprazole—Rash—Rivastigmine—Alzheimer's disease	5.87e-05	0.000344	CcSEcCtD
Lansoprazole—Dermatitis—Rivastigmine—Alzheimer's disease	5.86e-05	0.000344	CcSEcCtD
Lansoprazole—Headache—Rivastigmine—Alzheimer's disease	5.83e-05	0.000342	CcSEcCtD
Lansoprazole—CYP3A4—nervous system—Alzheimer's disease	5.74e-05	0.0128	CbGeAlD
Lansoprazole—Nausea—Memantine—Alzheimer's disease	5.65e-05	0.000331	CcSEcCtD
Lansoprazole—CYP2D6—nervous system—Alzheimer's disease	5.65e-05	0.0126	CbGeAlD
Lansoprazole—Nausea—Rivastigmine—Alzheimer's disease	5.53e-05	0.000324	CcSEcCtD
Lansoprazole—CYP3A4—central nervous system—Alzheimer's disease	5.52e-05	0.0123	CbGeAlD
Lansoprazole—CYP2D6—central nervous system—Alzheimer's disease	5.44e-05	0.0121	CbGeAlD
Lansoprazole—CYP2D6—cerebellum—Alzheimer's disease	5.31e-05	0.0119	CbGeAlD
Lansoprazole—CYP2D6—brain—Alzheimer's disease	4.32e-05	0.00963	CbGeAlD
Lansoprazole—ABCB1—nervous system—Alzheimer's disease	4.06e-05	0.00906	CbGeAlD
Lansoprazole—ABCB1—central nervous system—Alzheimer's disease	3.91e-05	0.00873	CbGeAlD
Lansoprazole—ABCB1—cerebellum—Alzheimer's disease	3.82e-05	0.00853	CbGeAlD
Lansoprazole—ABCB1—brain—Alzheimer's disease	3.1e-05	0.00693	CbGeAlD
Lansoprazole—CYP1B1—Metabolism—HMOX1—Alzheimer's disease	6.61e-06	8.37e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PLD3—Alzheimer's disease	6.58e-06	8.33e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GAPDH—Alzheimer's disease	6.49e-06	8.23e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	6.42e-06	8.13e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	6.36e-06	8.06e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	6.3e-06	7.99e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CHAT—Alzheimer's disease	6.28e-06	7.96e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—TPI1—Alzheimer's disease	6.28e-06	7.96e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—A2M—Alzheimer's disease	6.27e-06	7.95e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	6.23e-06	7.9e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	6.2e-06	7.85e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—TPI1—Alzheimer's disease	6.13e-06	7.77e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CHAT—Alzheimer's disease	6.13e-06	7.77e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	6.1e-06	7.73e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	6.07e-06	7.69e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—LPL—Alzheimer's disease	6.04e-06	7.65e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PPARGC1A—Alzheimer's disease	6.04e-06	7.65e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—MAOB—Alzheimer's disease	6.02e-06	7.63e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—HMOX1—Alzheimer's disease	6.01e-06	7.61e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PPARG—Alzheimer's disease	5.98e-06	7.58e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ACHE—Alzheimer's disease	5.95e-06	7.54e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—NOS3—Alzheimer's disease	5.89e-06	7.46e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—INPP5D—Alzheimer's disease	5.88e-06	7.45e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—MAOB—Alzheimer's disease	5.88e-06	7.45e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—INS—Alzheimer's disease	5.87e-06	7.43e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ND1—Alzheimer's disease	5.86e-06	7.42e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	5.85e-06	7.41e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	5.8e-06	7.34e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CHAT—Alzheimer's disease	5.78e-06	7.32e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—TPI1—Alzheimer's disease	5.78e-06	7.32e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	5.73e-06	7.26e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CHAT—Alzheimer's disease	5.73e-06	7.25e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—TPI1—Alzheimer's disease	5.73e-06	7.25e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	5.68e-06	7.19e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GAPDH—Alzheimer's disease	5.66e-06	7.17e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—A2M—Alzheimer's disease	5.6e-06	7.09e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	5.59e-06	7.08e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ENO1—Alzheimer's disease	5.58e-06	7.06e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTGS1—Alzheimer's disease	5.58e-06	7.06e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—MAOB—Alzheimer's disease	5.54e-06	7.02e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—LPL—Alzheimer's disease	5.5e-06	6.96e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—MAOB—Alzheimer's disease	5.49e-06	6.96e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CYP2D6—Alzheimer's disease	5.47e-06	6.93e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—A2M—Alzheimer's disease	5.46e-06	6.92e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	5.46e-06	6.92e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ACHE—Alzheimer's disease	5.46e-06	6.91e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—MTHFR—Alzheimer's disease	5.44e-06	6.89e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—INPP5D—Alzheimer's disease	5.39e-06	6.83e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PTGS2—Alzheimer's disease	5.39e-06	6.82e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	5.33e-06	6.75e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	5.33e-06	6.75e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	5.29e-06	6.7e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	5.23e-06	6.62e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—BCHE—Alzheimer's disease	5.18e-06	6.57e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	5.18e-06	6.56e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—A2M—Alzheimer's disease	5.15e-06	6.52e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—NOS3—Alzheimer's disease	5.15e-06	6.52e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ENO1—Alzheimer's disease	5.11e-06	6.48e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTGS1—Alzheimer's disease	5.11e-06	6.48e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—A2M—Alzheimer's disease	5.1e-06	6.47e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CALM1—Alzheimer's disease	5.08e-06	6.44e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—APOE—Alzheimer's disease	5.06e-06	6.42e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—CAV1—Alzheimer's disease	5.02e-06	6.36e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	5.01e-06	6.35e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	4.99e-06	6.32e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—MTHFR—Alzheimer's disease	4.95e-06	6.27e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—TPI1—Alzheimer's disease	4.89e-06	6.2e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CHAT—Alzheimer's disease	4.89e-06	6.2e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PLCB1—Alzheimer's disease	4.89e-06	6.2e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ACHE—Alzheimer's disease	4.87e-06	6.17e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	4.81e-06	6.1e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.8e-06	6.08e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ACHE—Alzheimer's disease	4.75e-06	6.02e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—BCHE—Alzheimer's disease	4.75e-06	6.02e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ABCA1—Alzheimer's disease	4.74e-06	6.01e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PTGS2—Alzheimer's disease	4.71e-06	5.96e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—INPP5D—Alzheimer's disease	4.7e-06	5.95e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—MAOB—Alzheimer's disease	4.69e-06	5.94e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CALM1—Alzheimer's disease	4.62e-06	5.86e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	4.61e-06	5.84e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—APOE—Alzheimer's disease	4.61e-06	5.84e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—CAV1—Alzheimer's disease	4.57e-06	5.78e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ENO1—Alzheimer's disease	4.56e-06	5.78e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	4.56e-06	5.78e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	4.55e-06	5.77e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	4.52e-06	5.72e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	4.49e-06	5.68e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ACHE—Alzheimer's disease	4.48e-06	5.67e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	4.48e-06	5.67e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	4.47e-06	5.66e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTGS1—Alzheimer's disease	4.45e-06	5.64e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ENO1—Alzheimer's disease	4.45e-06	5.64e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ACHE—Alzheimer's disease	4.44e-06	5.63e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	4.43e-06	5.61e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	4.42e-06	5.6e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PPARG—Alzheimer's disease	4.41e-06	5.59e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.4e-06	5.57e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	4.39e-06	5.56e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	4.37e-06	5.53e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—A2M—Alzheimer's disease	4.36e-06	5.53e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	4.35e-06	5.51e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—INS—Alzheimer's disease	4.33e-06	5.48e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—BCHE—Alzheimer's disease	4.24e-06	5.37e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ENO1—Alzheimer's disease	4.2e-06	5.32e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	4.2e-06	5.32e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	4.16e-06	5.27e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ENO1—Alzheimer's disease	4.16e-06	5.27e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—BCHE—Alzheimer's disease	4.14e-06	5.25e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PPARGC1A—Alzheimer's disease	4.09e-06	5.18e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	4.08e-06	5.17e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—HMOX1—Alzheimer's disease	4.07e-06	5.15e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PPARG—Alzheimer's disease	4.01e-06	5.08e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	4e-06	5.07e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—INS—Alzheimer's disease	3.94e-06	4.99e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.93e-06	4.97e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PLCB1—Alzheimer's disease	3.91e-06	4.95e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—BCHE—Alzheimer's disease	3.9e-06	4.94e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.89e-06	4.93e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	3.88e-06	4.92e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—BCHE—Alzheimer's disease	3.87e-06	4.9e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ACHE—Alzheimer's disease	3.79e-06	4.81e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—NOS3—Alzheimer's disease	3.79e-06	4.81e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ABCA1—Alzheimer's disease	3.79e-06	4.8e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—TPI1—Alzheimer's disease	3.78e-06	4.78e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CHAT—Alzheimer's disease	3.78e-06	4.78e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	3.75e-06	4.75e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	3.75e-06	4.75e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	3.73e-06	4.72e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—LPL—Alzheimer's disease	3.72e-06	4.71e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	3.68e-06	4.66e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	3.65e-06	4.62e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—MAOB—Alzheimer's disease	3.62e-06	4.59e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.58e-06	4.54e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	3.57e-06	4.52e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	3.56e-06	4.5e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ENO1—Alzheimer's disease	3.56e-06	4.5e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	3.54e-06	4.48e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	3.49e-06	4.42e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	3.49e-06	4.42e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTGS2—Alzheimer's disease	3.47e-06	4.4e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—NOS3—Alzheimer's disease	3.45e-06	4.37e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—LPL—Alzheimer's disease	3.41e-06	4.32e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—A2M—Alzheimer's disease	3.37e-06	4.26e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—MTHFR—Alzheimer's disease	3.35e-06	4.24e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	3.34e-06	4.24e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	3.33e-06	4.22e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—BCHE—Alzheimer's disease	3.31e-06	4.19e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	3.26e-06	4.14e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—HMOX1—Alzheimer's disease	3.25e-06	4.12e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTGS2—Alzheimer's disease	3.16e-06	4e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CALM1—Alzheimer's disease	3.13e-06	3.96e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	3.12e-06	3.95e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—APOE—Alzheimer's disease	3.12e-06	3.95e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CAV1—Alzheimer's disease	3.09e-06	3.91e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	3.08e-06	3.9e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	3.07e-06	3.89e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	3.06e-06	3.88e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.06e-06	3.88e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	3.05e-06	3.86e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—LPL—Alzheimer's disease	3.04e-06	3.86e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	3.04e-06	3.85e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	3.02e-06	3.83e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—LPL—Alzheimer's disease	2.97e-06	3.76e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ACHE—Alzheimer's disease	2.93e-06	3.71e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	2.89e-06	3.67e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CALM1—Alzheimer's disease	2.87e-06	3.64e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—APOE—Alzheimer's disease	2.86e-06	3.62e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CAV1—Alzheimer's disease	2.83e-06	3.59e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—LPL—Alzheimer's disease	2.8e-06	3.55e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—LPL—Alzheimer's disease	2.78e-06	3.52e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	2.74e-06	3.48e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ENO1—Alzheimer's disease	2.74e-06	3.48e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	2.74e-06	3.47e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PPARG—Alzheimer's disease	2.72e-06	3.44e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—AKT1—Alzheimer's disease	2.71e-06	3.43e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	2.69e-06	3.41e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—MTHFR—Alzheimer's disease	2.68e-06	3.39e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—INS—Alzheimer's disease	2.66e-06	3.38e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	2.61e-06	3.3e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	2.59e-06	3.29e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CALM1—Alzheimer's disease	2.56e-06	3.24e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOE—Alzheimer's disease	2.55e-06	3.23e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—BCHE—Alzheimer's disease	2.55e-06	3.23e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CAV1—Alzheimer's disease	2.53e-06	3.2e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	2.52e-06	3.19e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CALM1—Alzheimer's disease	2.5e-06	3.17e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	2.5e-06	3.17e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOE—Alzheimer's disease	2.49e-06	3.16e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PPARG—Alzheimer's disease	2.49e-06	3.16e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CAV1—Alzheimer's disease	2.47e-06	3.13e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—INS—Alzheimer's disease	2.44e-06	3.09e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	2.41e-06	3.05e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—LPL—Alzheimer's disease	2.37e-06	3.01e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—AKT1—Alzheimer's disease	2.37e-06	3e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CALM1—Alzheimer's disease	2.36e-06	2.98e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOE—Alzheimer's disease	2.35e-06	2.97e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—NOS3—Alzheimer's disease	2.34e-06	2.96e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CALM1—Alzheimer's disease	2.34e-06	2.96e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	2.33e-06	2.96e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOE—Alzheimer's disease	2.33e-06	2.95e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CAV1—Alzheimer's disease	2.33e-06	2.95e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CAV1—Alzheimer's disease	2.31e-06	2.92e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PPARG—Alzheimer's disease	2.22e-06	2.82e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—INS—Alzheimer's disease	2.18e-06	2.76e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPARG—Alzheimer's disease	2.17e-06	2.75e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—NOS3—Alzheimer's disease	2.14e-06	2.71e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTGS2—Alzheimer's disease	2.14e-06	2.71e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	2.14e-06	2.71e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—INS—Alzheimer's disease	2.13e-06	2.7e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPARG—Alzheimer's disease	2.04e-06	2.59e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPARG—Alzheimer's disease	2.03e-06	2.57e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2.01e-06	2.55e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—INS—Alzheimer's disease	2.01e-06	2.54e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	2e-06	2.54e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CALM1—Alzheimer's disease	2e-06	2.53e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOE—Alzheimer's disease	1.99e-06	2.52e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—INS—Alzheimer's disease	1.99e-06	2.52e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CAV1—Alzheimer's disease	1.97e-06	2.5e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	1.96e-06	2.48e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—NOS3—Alzheimer's disease	1.91e-06	2.42e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.87e-06	2.36e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.83e-06	2.32e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.76e-06	2.23e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	1.75e-06	2.22e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—AKT1—Alzheimer's disease	1.74e-06	2.21e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.74e-06	2.21e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPARG—Alzheimer's disease	1.73e-06	2.19e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.71e-06	2.16e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—INS—Alzheimer's disease	1.7e-06	2.15e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.65e-06	2.09e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.61e-06	2.04e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.59e-06	2.02e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—AKT1—Alzheimer's disease	1.59e-06	2.01e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.54e-06	1.95e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.53e-06	1.94e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.52e-06	1.93e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.49e-06	1.89e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.36e-06	1.73e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.34e-06	1.69e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—INS—Alzheimer's disease	1.31e-06	1.66e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.15e-06	1.46e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AKT1—Alzheimer's disease	1.07e-06	1.36e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.05e-06	1.33e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AKT1—Alzheimer's disease	9.85e-07	1.25e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AKT1—Alzheimer's disease	8.79e-07	1.11e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AKT1—Alzheimer's disease	8.58e-07	1.09e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AKT1—Alzheimer's disease	8.08e-07	1.02e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AKT1—Alzheimer's disease	8.01e-07	1.02e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AKT1—Alzheimer's disease	6.85e-07	8.68e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AKT1—Alzheimer's disease	5.29e-07	6.7e-06	CbGpPWpGaD
